Print Page   |   Contact Us   |   Your Cart   |   Sign In
Sign In

Breaking News
News & Press: Daily Updates

Oral Smallpox Treatment Gains FDA NDA Acceptance and Priority Review

Thursday, February 15, 2018   (0 Comments)
Posted by: Samantha Auguin

The US Food and Drug Administration (FDA) has accepted SIGA Technologies, Inc's New Drug Application (NDA) for its oral formulation of the smallpox medication, tecovirimat (TPOXX).

More >>

OSAP Disclaimer | Please notify our webmaster of any problems with this website.
OSAP thanks its Super Sponsors for their support in 2018. Sponsorship does not imply endorsement by OSAP of a company's products or services.